Research Article

Diagnostic and Prognostic Nomograms for Lung Metastasis in Triple-Negative Breast Cancer

Table 1

Clinical and pathological features of patients with TNBC.

Training cohort
(18936)
Validation cohort
(8112)
value

Age, years4.9530.084
 ≤402004 (10.6%)933 (11.5%)
 41-609033 (47.7%)3833 (47.3%)
 >607899 (41.7%)3346 (41.2%)
Tumour size, cm0.0330.983
 ≤516573 (87.5%)7099 (87.5%)
 5.1-102005 (10.6%)862 (10.6%)
 >10358 (1.9%)151 (1.9%)
Race0.2930.864
 White13570 (71.7%)5832 (71.9%)
 Black3913 (20.7%)1653 (20.4%)
 Other1453 (7.7%)627 (7.7%)
Grade8.1620.043
 I358 (1.9%)179 (2.2%)
 II3249 (17.2%)1321 (16.3%)
 III15166 (80.1%)6557 (80.8%)
 IV163 (0.9%)55 (0.7%)
Histological type<0.0010.999
 850016268 (85.9%)6969 (85.9%)
 Other2668 (14.1%)1143 (14.1%)
T stage0.6100.894
 T17976 (42.1%)3394 (41.8%)
 T28133 (42.9%)3485 (43.0%)
 T31735 (9.2%)747 (9.2%)
 T41092 (5.8%)486 (6.0%)
N stage0.1320.716
 N012153 (64.2%)5225 (64.4%)
 Nx6783 (35.8%)2887 (35.6%)
Lung metastasis1.6350.201
 No18590 (98.2%)7945 (97.9%)
 Yes346 (1.8%)167 (2.1%)
Insurance0.5130.474
 No435 (2.3%)198 (2.4%)
 Yes18501 (97.7%)7914 (97.6%)
Marital status0.2740.601
 No8289 (43.8%)3523 (43.4%)
 Yes10647 (56.2%)4589 (56.6%)